{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:56:49Z","timestamp":1762005409179,"version":"3.44.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"am","delay-in-days":314,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24DK081913"],"award-info":[{"award-number":["K24DK081913"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.metabol.2022.155265","type":"journal-article","created":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T18:27:50Z","timestamp":1657391270000},"page":"155265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["PCSK9 and ANGPTL3 levels correlate with hyperlipidemia in HIV-lipoatrophy, are regulated by fasting and are not affected by leptin administered in physiologic or pharmacologic doses"],"prefix":"10.1016","volume":"134","author":[{"given":"Eirini","family":"Bouzoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Perakakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margery A.","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeliki M.","family":"Angelidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Pilitsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Farr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Stefanakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.metabol.2022.155265_bb0005","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1038\/s41467-020-18885-9","article-title":"Leptin alters energy intake and fat mass but not energy expenditure in lean subjects","volume":"11","author":"Chrysafi","year":"2020","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.metabol.2022.155265_bb0010","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jacc.2020.11.069","article-title":"Leptin in leanness and obesity: JACC state-of-the-art review","volume":"77","author":"Perakakis","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2022.155265_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154392","article-title":"Circulating profile of activin-follistatin-inhibin Axis in women with hypothalamic amenorrhea in response to leptin treatment","volume":"113","author":"Bouzoni","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2022.155265_bb0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.metabol.2019.05.001","article-title":"Fatty liver in lipodystrophy: a review with a focus on therapeutic perspectives of adiponectin and\/or leptin replacement","volume":"96","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.metabol.2022.155265_bb0025","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/367859","article-title":"Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin","volume":"36","author":"Nagy","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.metabol.2022.155265_bb0030","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/01.CIR.104.3.257","article-title":"Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction","volume":"104","author":"Stein","year":"2001","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.metabol.2022.155265_bb0035","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1210\/jc.2005-1545","article-title":"Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy","volume":"91","author":"Lee","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.metabol.2022.155265_bb0040","first-page":"1600","article-title":"Cardiovascular efficacy and safety of PCSK9 inhibitors: systematic review and meta-analysis including the ODYSSEY OUTCOMES trial","volume":"34","author":"Turgeon","year":"2018","journal-title":"Can J Cardiol"},{"issue":"2","key":"10.1016\/j.metabol.2022.155265_bb0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1253\/circj.CJ-18-0442","article-title":"ANGPTL3 inhibitors- their role in cardiovascular disease through regulation of lipid metabolism","volume":"83","author":"Geladari","year":"2019","journal-title":"Circ J"},{"issue":"10","key":"10.1016\/j.metabol.2022.155265_bb0050","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrendo.2015.122","article-title":"Metabolic functions of FABPs\u2013mechanisms and therapeutic implications","volume":"11","author":"Hotamisligil","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.metabol.2022.155265_bb0055","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41574-018-0110-5","article-title":"Inhibiting PCSK9 - biology beyond LDL control","volume":"15","author":"Stoekenbroek","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2022.155265_bb0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12916-015-0358-8","article-title":"Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials","volume":"13","author":"Zhang","year":"2015","journal-title":"BMC Med"},{"issue":"6","key":"10.1016\/j.metabol.2022.155265_bb0065","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/jamacardio.2019.0911","article-title":"2018 American Heart Association\/American College of Cardiology\/Multisociety guideline on the Management of Blood Cholesterol-Secondary Prevention","volume":"4","author":"Grundy","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.metabol.2022.155265_bb0070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12020-015-0838-9","article-title":"The role of ANGPTL3 in controlling lipoprotein metabolism","volume":"52","author":"Tikka","year":"2016","journal-title":"Endocrine"},{"issue":"24","key":"10.1016\/j.metabol.2022.155265_bb0075","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa2031049","article-title":"Evinacumab in patients with refractory hypercholesterolemia","volume":"383","author":"Rosenson","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.metabol.2022.155265_bb0080","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142245","article-title":"Severe insulin resistance syndromes","volume":"131","author":"Angelidi","year":"2021","journal-title":"J Clin Invest"},{"issue":"319","key":"10.1016\/j.metabol.2022.155265_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac6336","article-title":"Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes","volume":"7","author":"Burak","year":"2015","journal-title":"Sci Transl Med"},{"issue":"9","key":"10.1016\/j.metabol.2022.155265_bb0090","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1172\/JCI200317490","article-title":"The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men","volume":"111","author":"Chan","year":"2003","journal-title":"J Clin Invest"},{"issue":"22","key":"10.1016\/j.metabol.2022.155265_bb0095","doi-asserted-by":"crossref","first-page":"8481","DOI":"10.1073\/pnas.0505429103","article-title":"Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans","volume":"103","author":"Chan","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.metabol.2022.155265_bb0100","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1210\/jc.2006-2864","article-title":"Pharmacokinetics of recombinant methionyl human leptin after subcutaneous administration: variation of concentration-dependent parameters according to assay","volume":"92","author":"Chan","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.metabol.2022.155265_bb0105","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2165\/00003088-200847110-00006","article-title":"Pharmacokinetics of subcutaneous recombinant methionyl human leptin administration in healthy subjects in the fed and fasting states: regulation by gender and adiposity","volume":"47","author":"Chan","year":"2008","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.metabol.2022.155265_bb0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons","volume":"1","author":"Rothman","year":"1990","journal-title":"Epidemiology"},{"issue":"6","key":"10.1016\/j.metabol.2022.155265_bb0115","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.21037\/jtd.2017.05.34","article-title":"A general introduction to adjustment for multiple comparisons","volume":"9","author":"Chen","year":"2017","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.metabol.2022.155265_bb0120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.metabol.2019.05.004","volume":"97","author":"Pilitsi","year":"2019","journal-title":"Metabolism"},{"issue":"16","key":"10.1016\/j.metabol.2022.155265_bb0125","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121434","article-title":"The circulating metabolome of human starvation","volume":"3","author":"Steinhauser","year":"2018","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.metabol.2022.155265_bb0130","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/ATVBAHA.110.214130","article-title":"Circulating proprotein convertase subtilisin kexin type 9 has a diurnal rhythm synchronous with cholesterol synthesis and is reduced by fasting in humans","volume":"30","author":"Persson","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.metabol.2022.155265_bb0135","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1194\/jlr.P009860","article-title":"Fasting reduces plasma proprotein convertase, subtilisin\/kexin type 9 and cholesterol biosynthesis in humans","volume":"51","author":"Browning","year":"2010","journal-title":"J Lipid Res"},{"issue":"11","key":"10.1016\/j.metabol.2022.155265_bb0140","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1172\/JCI2961","article-title":"Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2","volume":"101","author":"Horton","year":"1998","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.metabol.2022.155265_bb0145","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/ATVBAHA.115.306032","article-title":"PCSK9 induces CD36 degradation and affects long-chain fatty acid uptake and triglyceride metabolism in adipocytes and in mouse liver","volume":"35","author":"Demers","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.metabol.2022.155265_bb0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41387-018-0032-2","article-title":"Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation","volume":"8","author":"Cinkajzlova","year":"2018","journal-title":"Nutr Diabetes"},{"issue":"3","key":"10.1016\/j.metabol.2022.155265_bb0155","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/MOL.0000000000000290","article-title":"Regulation of lipid metabolism by angiopoietin-like proteins","volume":"27","author":"Dijk","year":"2016","journal-title":"Curr Opin Lipidol"},{"issue":"3","key":"10.1016\/j.metabol.2022.155265_bb0160","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1194\/jlr.P069039","article-title":"HDL efflux capacity, HDL particle size, and high-risk carotid atherosclerosis in a cohort of asymptomatic older adults: the Chicago healthy aging study","volume":"58","author":"Mutharasan","year":"2017","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.metabol.2022.155265_bb0165","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.116.305485","article-title":"HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export","volume":"116","author":"Du","year":"2015","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.metabol.2022.155265_bb0170","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1210\/jc.2016-2144","article-title":"Cholesterol efflux capacity and subclasses of HDL particles in healthy women transitioning through menopause","volume":"101","author":"El Khoudary","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"25","key":"10.1016\/j.metabol.2022.155265_bb0175","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.metabol.2022.155265_bb0180","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.004861","article-title":"Peroxisome proliferator-activated receptor-gamma in capillary endothelia promotes fatty acid uptake by heart during long-term fasting","volume":"2","author":"Goto","year":"2013","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.metabol.2022.155265_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7120505","article-title":"Fatty acid-binding protein 4-an \"Inauspicious\" adipokine-in serum and urine of post-partum women with excessive gestational weight gain and gestational diabetes mellitus","volume":"7","author":"Kimber-Trojnar","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.metabol.2022.155265_bb0190","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6578327","article-title":"Effects of angiopoietin-like 3 on triglyceride regulation, glucose homeostasis, and diabetes","volume":"2019","author":"Christopoulou","year":"2019","journal-title":"Dis Markers"},{"issue":"19","key":"10.1016\/j.metabol.2022.155265_bb0195","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009996","article-title":"Coronary endothelial dysfunction is associated with elevated serum PCSK9 levels in people with HIV independent of low-density lipoprotein cholesterol","volume":"7","author":"Leucker","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metabol.2022.155265_bb0200","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.atherosclerosis.2019.02.015","article-title":"Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients naive of statin therapy: a cross-sectional analysis from the swiss HIV cohort","volume":"284","author":"Gencer","year":"2019","journal-title":"Atherosclerosis"},{"issue":"20","key":"10.1016\/j.metabol.2022.155265_bb0205","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1016\/j.jacc.2020.03.025","article-title":"Evolocumab in HIV-infected patients with dyslipidemia: primary results of the randomized, double-blind BEIJERINCK study","volume":"75","author":"Boccara","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.metabol.2022.155265_bb0210","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1210\/en.2015-1624","article-title":"Effect of leptin replacement on PCSK9 in ob\/ob mice and female lipodystrophic patients","volume":"157","author":"Levenson","year":"2016","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.metabol.2022.155265_bb0215","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jacl.2017.02.002","article-title":"Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy","volume":"11","author":"Muniyappa","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"6","key":"10.1016\/j.metabol.2022.155265_bb0220","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/ijo.2014.215","article-title":"Lack of Day\/Night variation in fibroblast growth factor 21 levels in young healthy men","volume":"39","author":"Foo","year":"2015","journal-title":"Int J Obes (Lond)"},{"issue":"4","key":"10.1016\/j.metabol.2022.155265_bb0225","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2337\/dc12-0497","article-title":"Fibroblast growth factor 21 levels in young healthy females display day and night variations and are increased in response to short-term energy deprivation through a leptin-independent pathway","volume":"36","author":"Foo","year":"2013","journal-title":"Diabetes Care"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049522001433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049522001433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:29:44Z","timestamp":1758428984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049522001433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":45,"alternative-id":["S0026049522001433"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155265","relation":{},"ISSN":["0026-0495"],"issn-type":[{"type":"print","value":"0026-0495"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PCSK9 and ANGPTL3 levels correlate with hyperlipidemia in HIV-lipoatrophy, are regulated by fasting and are not affected by leptin administered in physiologic or pharmacologic doses","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155265"}}